References
- Rotmensch H H, Liron M, Tupilski M, Laniado S. Possible association of pneumonitis with amiodarone therapy (letter). Am Heart J 1980; 100: 412–413
- Sobol S M, Rakita L. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: A possible complication of a new antiarrhythmic drug. Circulation 1982; 65: 819–824
- Marchlinski F E, Gansler T S, Waxman H L, Josephson M E. Amiodarone pulmonary toxicity. Ann Intern Med 1982; 97: 839–845
- Riley S A, Williams S E, Cooke N J. Alveolitis after treatment with amiodarone. Br Med J 1982; 284: 161–162
- Snider G L, Celli B R, Goldstein R H, O'Brien J J, Lucey E C. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 1978; 117: 289–297
- Snider G L, Hayes J A, Korthy A L. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 1978; 117: 1099–1108
- Spencer H. Pathology of the Lung. Pergamon Press, New York 1977; 707–708
- Ryan S F. Experimental fibrosing alveolitis. Am Rev Respir Dss 1972; 105: 776–790
- Zipes D P, Troup P J. New antiarrhythmic agents: Amiodarone, aprindine, disopyram-ide, ethmozin, mexiletine, tocainide, verapamil. Am J Cardiol 1978; 41: 1005–1024
- Vos A K, van Ramshorst A GS, Grosfeld J CM, Goossens J P. A peculiar cutaneous pigmentation from cordarone. Dermatologica 1972; 145: 297–303
- Delage C, Lagacé R, Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: A light and electron microscopic study. Can Med Assoc J 1975; 112: 1205–1208
- Ingram D V. Ocular changes during oral amiodarone treatment. Amiodarone and Cardiac Arrhythmias: Royal Society of Medicine International Congress and Symposium. Series 16. Academic Press, London 1978; 57–61
- Vénn PH, Vildy A. The oculocutaneous effects of amiodarone. Amiodarone and Cardiac Arrhythmias: Royal Society of Medicine International Congress and Symposium. Series 16. Academic Press, London 1978; 63–66
- Jonckheer M H, Blockx P, Kaivers R, Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol (Brux) 1973; 28: 192–200
- Burger A, Dinichert D, Nicod P, Jenny M, Lemarchand-Béraud T, Vallotton M B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and Thyrotropin: A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 1976; 58: 255–259
- Meier C, Kauer B, Miiller U, Ludin H P. Neuromyopathy during chronic amiodarone treatment: A case report. J Neurol 1979; 220: 231–239
- Lustman F, Monseu G. Amiodarone and neurological side effects (letter). Lancet 1974; 1: 568
- Carrington C B. Organizing interstitial pneumonia: Definition of the lesion and attempts to devise an experimental model. Yale J Biol Med 1968; 40: 352–363